glp-1 obesity drug news today oct 2025 Chart: 1 in 8 Americans Now Use Drugs for Weight Loss ADA '26: Lilly's dominance, Pfizer's

Wegovy (semaglutide) Product Information (PDF)

D&D Pharmatech

Orforglipron is a GLP-1 receptor agonist developed by Eli Lilly 1

What Medicare Already Covers for Weight Management Even without the GLP-1 Bridge (which doesn't start until July 2026), Medicare already covers several weight management services that many beneficiaries don't know about: Current Medicare Weight Management Benefits Obesity Behavioral Counseling (Part B): If your BMI is 30 or higher, Medicare covers up to 22 intensive behavioral therapy sessions over 12 months with your primary care provider, at no cost to you Medical Nutrition Therapy (Part B): If you have diabetes or kidney disease, Medicare covers nutritional counseling sessions with a registered dietitian Diabetes Self-Management Training: Covers education on managing blood sugar, diet, and exercise Bariatric Surgery (Part A): Medicare covers certain weight loss surgeries if medically necessary These preventive services are often overlooked, but they can be a solid starting point, especially while waiting for GLP-1 coverage to become available

#Menopause #GLP1 #Perimenopause #WomensHealth A study published in The Lancet Psychiatry in April 2026 tracked nearly 100,000 people with diagnosed depression or anxiety across more than a decade of Swedish national health data

MHRA urges women taking weight loss drugs to use effective contraception